Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(21 sites)

United States

San Tan Allergy & Asthma, Gilbert, Arizona

Children's Hospital of Orange County, Orange, California

DaVinci Research, LLC, Sacramento, California

Breathe Clear Institute, Torrance, California

Children's Hospital Colorado, Aurora, Colorado

Colorado ENT & Allergy, Colorado Springs, Colorado

Children's Healthcare of Atlanta, Atlanta, Georgia

Southern Illinois University School of Medicine, Springfield, Illinois

Kentuckiana ENT, Louisville, Kentucky

Centers for Advanced ENT Care, Towson, Maryland

University of Missouri Medical Center, Columbia, Missouri

University of Rochester Medical Center, Rochester, New York

Allergy, Asthma and Clinical Research Center, Oklahoma City, Oklahoma

Vital Prospects Clinical Research Institute, Tulsa, Oklahoma

Charleston ENT & Allergy, North Charleston, South Carolina

Carolina ENT Clinic/CENTRI Inc., Orangeburg, South Carolina

Orion Clinical Research, Austin, Texas

STAAMP Research, San Antonio, Texas

Alamo ENT Associates, San Antonio, Texas

University of Utah, Salt Lake City, Utah

EVMS at Old Dominion University, Norfolk, Virginia